🔗 Share this article Social Media Content Creators Fueling Unofficial Market for Unapproved Slimming Drug A shadow economy for unapproved slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings. Investigational Treatment Acquiring Popularity Online The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts directly for source information, while also receiving discount codes. Active Trade on Social Networks Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases. Understanding The Experimental Drug Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic. Medical Experts Express Concerns However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering products of unknown origin. Some experts said the demand for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro. Regulatory Status and Enforcement Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations. Some content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, risking fines, prosecution or prison. Service Response and Content Removal According to TikTok, the platform has taken down problematic content and prohibited associated keywords and search suggestions. The company stated it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies. Digital Trading Operations Research also found groups with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or administering at residence. Within moments of entering one community, a seller shared contact information, where most transactions take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, health issues or previous experience. Item Information and Pricing Within these communities, posts show black plastic parcels with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.” Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”. Platform Oversight and Safety Actions A spokesperson for Telegram stated it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Medical Professional Warnings “People are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U. A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained. Her team has already seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.” Producer Position A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental product not yet approved … may subject users to potentially significant medical dangers”.